SynthesisBMC infectious diseases2025

Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis.

Abdulmajeed M Alshehri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.